| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-05-22 15:12:43 UTC |
|---|
| Update Date | 2022-03-07 02:49:18 UTC |
|---|
| HMDB ID | HMDB0003229 |
|---|
| Secondary Accession Numbers | - HMDB0060082
- HMDB03229
- HMDB60082
|
|---|
| Metabolite Identification |
|---|
| Common Name | Palmitoleic acid |
|---|
| Description | Palmitoleic acid, or (9Z)-hexadec-9-enoic acid, is an omega-7 monounsaturated fatty acid (16:1n-7) with the formula CH3(CH2)5CH=CH(CH2)7COOH that is a common constituent of the glycerides of human adipose tissue. Present in all tissues, it is generally found in higher concentrations in the liver. Macadamia oil (Macadamia integrifolia) and sea buckthorn oil (Hippophae rhamnoides) are botanical sources of palmitoleic acid, containing 22 and 40% respectively. Palmitoleic acid is found to be associated with isovaleric acidemia, which is an inborn error of metabolism. |
|---|
| Structure | InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/b8-7- |
|---|
| Synonyms | | Value | Source |
|---|
| (9Z)-Hexadecenoic acid | ChEBI | | (Z)-9-Hexadecenoic acid | ChEBI | | (Z)-Hexadec-9-enoic acid | ChEBI | | 16:1DElta9 | ChEBI | | 9-cis-Hexadecenoic acid | ChEBI | | cis-9-Hexadecenoic acid | ChEBI | | cis-9-Palmitoleic acid | ChEBI | | cis-delta-9-Hexadecenoic acid | ChEBI | | cis-Delta(9)-Hexadecenoic acid | ChEBI | | cis-Palmitoleic acid | ChEBI | | Oleopalmitic acid | ChEBI | | Palmitolinoleic acid | ChEBI | | Zoomaric acid | ChEBI | | Zoomeric acid | ChEBI | | (9Z)-Hexadec-9-enoate | Kegg | | (9Z)-Hexadecenoate | Generator | | (Z)-9-Hexadecenoate | Generator | | (Z)-Hexadec-9-enoate | Generator | | 9-cis-Hexadecenoate | Generator | | cis-9-Hexadecenoate | Generator | | cis-9-Palmitoleate | Generator | | cis-delta-9-Hexadecenoate | Generator | | cis-Δ-9-hexadecenoate | Generator | | cis-Δ-9-hexadecenoic acid | Generator | | cis-delta(9)-Hexadecenoate | Generator | | cis-Δ(9)-hexadecenoate | Generator | | cis-Δ(9)-hexadecenoic acid | Generator | | cis-Palmitoleate | Generator | | Oleopalmitate | Generator | | Palmitolinoleate | Generator | | Zoomarate | Generator | | Zoomerate | Generator | | (9Z)-Hexadec-9-enoic acid | Generator | | Palmitoleate | Generator | | 9-Hexadecenoate | HMDB | | 9-Hexadecenoic acid | HMDB | | Hexadecenoate | HMDB | | Hexadecenoate (N-C16:1) | HMDB | | Hexadecenoic acid | HMDB | | Palmitoleic acid, (Z)-isomer | HMDB | | Palmitoleic acid, (e)-isomer | HMDB | | C16:1 trans-9 | HMDB | | Palmitelaidic acid | HMDB | | (9Z)-9-Hexadecenoic acid | HMDB | | 9Z-Hexadecenoic acid | HMDB | | C16:1 | HMDB | | FA(16:1(9Z)) | HMDB | | FA(16:1n7) | HMDB | | cis-delta9-Hexadecenoic acid | HMDB | | cis-Δ9-hexadecenoic acid | HMDB | | Palmitoleic acid | HMDB |
|
|---|
| Chemical Formula | C16H30O2 |
|---|
| Average Molecular Weight | 254.4082 |
|---|
| Monoisotopic Molecular Weight | 254.224580204 |
|---|
| IUPAC Name | (9Z)-hexadec-9-enoic acid |
|---|
| Traditional Name | palmitoleic acid |
|---|
| CAS Registry Number | 373-49-9 |
|---|
| SMILES | CCCCCC\C=C/CCCCCCCC(O)=O |
|---|
| InChI Identifier | InChI=1S/C16H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h7-8H,2-6,9-15H2,1H3,(H,17,18)/b8-7- |
|---|
| InChI Key | SECPZKHBENQXJG-FPLPWBNLSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as long-chain fatty acids. These are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Fatty Acyls |
|---|
| Sub Class | Fatty acids and conjugates |
|---|
| Direct Parent | Long-chain fatty acids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Long-chain fatty acid
- Unsaturated fatty acid
- Straight chain fatty acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Liquid |
|---|
| Experimental Molecular Properties | |
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 10.29 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 22.3118 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.94 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 34.2 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 2923.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 614.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 242.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 370.0 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 566.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 977.2 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 777.6 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 95.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2081.8 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 613.7 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1782.1 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 760.0 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 480.1 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 648.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 589.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.0 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| Spectra |
|---|
| |
|---|
| Biological Properties |
|---|
| Cellular Locations | - Extracellular
- Membrane (predicted from logP)
|
|---|
| Biospecimen Locations | - Blood
- Cerebrospinal Fluid (CSF)
- Feces
- Saliva
- Urine
|
|---|
| Tissue Locations | - Adipose Tissue
- Placenta
- Prostate
- Skeletal Muscle
|
|---|
| Pathways | |
|---|
| Normal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 13 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 1.9-6.3 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 244.4 +/- 108.9 uM | Adult (>18 years old) | Not Specified | Normal | | details | | Blood | Detected and Quantified | 250 +/- 70 uM | Adult (>18 years old) | Male | Normal | | details | | Blood | Detected and Quantified | 240 +/- 100 uM | Adult (>18 years old) | Female | Normal | | details | | Blood | Detected and Quantified | 19.0639 +/- 11.674 uM | Adult (>18 years old) | Female | Normal | | details | | Blood | Detected and Quantified | 34 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 28 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 27 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 21 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 18 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 15 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 12 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 8 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 31.0 (5.0-85.0) uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 4.5 +/- 2.8 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 6.390 +/- 4.279 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 14.7 +/- 0.169 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 9.66 +/- 6.8 uM | Adult (>18 years old) | Both | Normal | | details | | Blood | Detected and Quantified | 7 uM | Adult (>18 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 2 uM | Children (1-13 years old) | Both | Normal | | details | | Cerebrospinal Fluid (CSF) | Detected and Quantified | 2.0 +/- 2.0 uM | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Infant (0-1 year old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Not Specified | Normal | | details | | Urine | Detected and Quantified | 2.8 (0.7-6.6) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected and Quantified | 0.03 +/- 0.02 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
|---|
| Abnormal Concentrations |
|---|
| |
| Blood | Detected and Quantified | 206.0 +/- 92.7 uM | Adult (>18 years old) | Not Specified | Isovaleric acidemia | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | liver cirrhosis | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details |
|
|---|
| Associated Disorders and Diseases |
|---|
| Disease References | | Isovaleric acidemia |
|---|
- Dercksen M, Kulik W, Mienie LJ, Reinecke CJ, Wanders RJ, Duran M: Polyunsaturated fatty acid status in treated isovaleric acidemia patients. Eur J Clin Nutr. 2016 Oct;70(10):1123-1126. doi: 10.1038/ejcn.2016.100. Epub 2016 Jun 22. [PubMed:27329611 ]
| | Cirrhosis |
|---|
- Huang HJ, Zhang AY, Cao HC, Lu HF, Wang BH, Xie Q, Xu W, Li LJ: Metabolomic analyses of faeces reveals malabsorption in cirrhotic patients. Dig Liver Dis. 2013 Aug;45(8):677-82. doi: 10.1016/j.dld.2013.01.001. Epub 2013 Feb 4. [PubMed:23384618 ]
| | Colorectal cancer |
|---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
|
|
|---|
| Associated OMIM IDs | |
|---|
| External Links |
|---|
| DrugBank ID | DB04257 |
|---|
| Phenol Explorer Compound ID | Not Available |
|---|
| FooDB ID | FDB031085 |
|---|
| KNApSAcK ID | C00001234 |
|---|
| Chemspider ID | 393216 |
|---|
| KEGG Compound ID | C08362 |
|---|
| BioCyc ID | CPD-9245 |
|---|
| BiGG ID | 246167 |
|---|
| Wikipedia Link | Palmitoleic acid |
|---|
| METLIN ID | 188 |
|---|
| PubChem Compound | 445638 |
|---|
| PDB ID | Not Available |
|---|
| ChEBI ID | 28716 |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | HDCEA |
|---|
| MarkerDB ID | MDB00030007 |
|---|
| Good Scents ID | rw1271951 |
|---|
| References |
|---|
| Synthesis Reference | Xu, Huashun; Luo, Yuping; Li, Siguang. Palmitoleic acid production by fermentation with yeast. Zhongguo Youzhi (1999), 24(6), 53-55. |
|---|
| Material Safety Data Sheet (MSDS) | Download (PDF) |
|---|
| General References | - Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Katsuta Y, Iida T, Inomata S, Denda M: Unsaturated fatty acids induce calcium influx into keratinocytes and cause abnormal differentiation of epidermis. J Invest Dermatol. 2005 May;124(5):1008-13. [PubMed:15854043 ]
- Rossner S, Walldius G, Bjorvell H: Fatty acid composition in serum lipids and adipose tissue in severe obesity before and after six weeks of weight loss. Int J Obes. 1989;13(5):603-12. [PubMed:2583914 ]
- Ho RC, Davy KP, Hickey MS, Summers SA, Melby CL: Behavioral, metabolic, and molecular correlates of lower insulin sensitivity in Mexican-Americans. Am J Physiol Endocrinol Metab. 2002 Oct;283(4):E799-808. [PubMed:12217898 ]
- Hori Y, Nakamura K, Yamamoto M, Shimada K, Nakadaira H, Shibuya N, Endoh K, Ogoshi K: Determination of free fatty acids in human bile by high-performance liquid chromatography. Ann Clin Biochem. 1998 Mar;35 ( Pt 2):279-82. [PubMed:9547901 ]
- Yli-Jama P, Haugen TS, Rebnord HM, Ringstad J, Pedersen JI: Selective mobilisation of fatty acids from human adipose tissue. Eur J Intern Med. 2001 Apr;12(2):107-115. [PubMed:11297913 ]
- Prandota J: Clinical pharmacology of antibiotics and other drugs in cystic fibrosis. Drugs. 1988 May;35(5):542-78. [PubMed:3293970 ]
- Thiele I, Swainston N, Fleming RM, Hoppe A, Sahoo S, Aurich MK, Haraldsdottir H, Mo ML, Rolfsson O, Stobbe MD, Thorleifsson SG, Agren R, Bolling C, Bordel S, Chavali AK, Dobson P, Dunn WB, Endler L, Hala D, Hucka M, Hull D, Jameson D, Jamshidi N, Jonsson JJ, Juty N, Keating S, Nookaew I, Le Novere N, Malys N, Mazein A, Papin JA, Price ND, Selkov E Sr, Sigurdsson MI, Simeonidis E, Sonnenschein N, Smallbone K, Sorokin A, van Beek JH, Weichart D, Goryanin I, Nielsen J, Westerhoff HV, Kell DB, Mendes P, Palsson BO: A community-driven global reconstruction of human metabolism. Nat Biotechnol. 2013 May;31(5):419-25. doi: 10.1038/nbt.2488. Epub 2013 Mar 3. [PubMed:23455439 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
|
|---|